Dose Escalation and Dose Expansion Study of CPO-100 in Patients With Advanced Solid Tumors
Conjupro Biotherapeutics, Inc.
Conjupro Biotherapeutics, Inc.
Sotio Biotech Inc.
Pfizer
Takeda
Ocellaris Pharma, Inc.
Actym Therapeutics, Inc.
Bolt Biotherapeutics, Inc.
3B Pharmaceuticals GmbH
NuCana plc
Telix Pharmaceuticals (Innovations) Pty Limited
Pfizer
Hutchmed
Kymab Limited
Seagen Inc.
Aminex Therapeutics, Inc.
Inhibrx Biosciences, Inc
Pfizer
Fusion Pharmaceuticals Inc.
Ipsen
Merck Sharp & Dohme LLC
Fate Therapeutics
Fate Therapeutics
Gossamer Bio Inc.
Incyte Corporation
Seagen Inc.
AIDS Malignancy Consortium
CureOne
National Institutes of Health Clinical Center (CC)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins